Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Biobanking Services Market, Global Research Reports 2020-2021

Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Biobanking Services Industry
  • 1.7 COVID-19 Impact: Biobanking Services Market Trends
  • 2 Global Biobanking Services Quarterly Market Size Analysis

    • 2.1 Biobanking Services Business Impact Assessment - COVID-19
      • 2.1.1 Global Biobanking Services Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Biobanking Services Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Biobanking Services Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Biobanking Services Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Biobanking Services Market
    • 3.4 Key Players Biobanking Services Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Biobanking Services Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Blood Products
      • 1.4.2 Human Tissues
      • 1.4.3 Cell Lines
      • 1.4.4 Nucleic Acids
    • 4.2 By Type, Global Biobanking Services Market Size, 2019-2021

    5 Impact of Covid-19 on Biobanking Services Segments, By Application

    • 5.1 Overview
      • 5.5.1 Regenerative Medicine
      • 5.5.2 Life Science
      • 5.5.3 Clinical Research
    • 5.2 By Application, Global Biobanking Services Market Size, 2019-2021
      • 5.2.1 By Application, Global Biobanking Services Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Qiagen N.V. (Germany)
      • 7.1.1 Qiagen N.V. (Germany) Business Overview
      • 7.1.2 Qiagen N.V. (Germany) Biobanking Services Quarterly Revenue, 2020
      • 7.1.3 Qiagen N.V. (Germany) Biobanking Services Product Introduction
      • 7.1.4 Qiagen N.V. (Germany) Response to COVID-19 and Related Developments
    • 7.2 Hamilton Company (US)
      • 7.2.1 Hamilton Company (US) Business Overview
      • 7.2.2 Hamilton Company (US) Biobanking Services Quarterly Revenue, 2020
      • 7.2.3 Hamilton Company (US) Biobanking Services Product Introduction
      • 7.2.4 Hamilton Company (US) Response to COVID-19 and Related Developments
    • 7.3 Brooks Automation (US)
      • 7.3.1 Brooks Automation (US) Business Overview
      • 7.3.2 Brooks Automation (US) Biobanking Services Quarterly Revenue, 2020
      • 7.3.3 Brooks Automation (US) Biobanking Services Product Introduction
      • 7.3.4 Brooks Automation (US) Response to COVID-19 and Related Developments
    • 7.4 TTP Labtech Ltd (U.K.)
      • 7.4.1 TTP Labtech Ltd (U.K.) Business Overview
      • 7.4.2 TTP Labtech Ltd (U.K.) Biobanking Services Quarterly Revenue, 2020
      • 7.4.3 TTP Labtech Ltd (U.K.) Biobanking Services Product Introduction
      • 7.4.4 TTP Labtech Ltd (U.K.) Response to COVID-19 and Related Developments
    • 7.5 VWR Corporation (US)
      • 7.5.1 VWR Corporation (US) Business Overview
      • 7.5.2 VWR Corporation (US) Biobanking Services Quarterly Revenue, 2020
      • 7.5.3 VWR Corporation (US) Biobanking Services Product Introduction
      • 7.5.4 VWR Corporation (US) Response to COVID-19 and Related Developments
    • 7.6 Promega Corporation (US)
      • 7.6.1 Promega Corporation (US) Business Overview
      • 7.6.2 Promega Corporation (US) Biobanking Services Quarterly Revenue, 2020
      • 7.6.3 Promega Corporation (US) Biobanking Services Product Introduction
      • 7.6.4 Promega Corporation (US) Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Biobanking Services, including the following market information:
      Global Biobanking Services Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Biobanking Services Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Biobanking Services Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Biobanking Services Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Qiagen N.V. (Germany), Hamilton Company (US), Brooks Automation (US), TTP Labtech Ltd (U.K.), VWR Corporation (US), Promega Corporation (US), etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Blood Products
      Human Tissues
      Cell Lines
      Nucleic Acids

      Based on the Application:
      Regenerative Medicine
      Life Science
      Clinical Research

      Buy now